Primary Prevention of Cardiovascular Disease

Tunstall-Pedoe H Smith WCS Crombie IK . Levels and trends of coronary heart disease mortality in Scotland compared with other countries. Health Bulletin 1986; 44: 153–161.

Shaper AG Pocock SJ Walter M Phillips AN Whitehead TP Macfarlane PW . Risk factors for ischaemic heart disease: The prospective phase of the British Regional Heart Study. J Epidemiol and Comm Health 1985; 39: 197–209.

World Health Organisation European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: Final report on the six-year results. Lancet 1986; i: 869–72.

Castelli WP . Epidemiology of coronary heart disease: The Framingham study. Amer J Med, 1984; 76(2A): 4–12.

Report of The British Cardiac Society working group on coronary disease prevention. London: British Cardiac Society 1987.

Cook DG Shaper AG Pocock SJ Kussick SJ . Giving up smoking and the risk of heart attacks. A report from the British Regional Heart Study. Lancet 1986; ii: 1376–1379.

Wikstrand J Warnold I Olsson G Tuomilento J Eimfeldt D Berglund G. Primary prevention with metoprolol in patients with hypertension: Mortality results from the MAPHY study. JAMA 1988; 259: 1976–1982.

Lipid Research Program. The lipid research clinics coronary prevention trial results II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984; 251: 365–374.

Lewis B. Management of the hyperlipidaemic patient. J Roy Coll Phys, London 1988; 22: 28–31.

Committee of Principal Investigators. A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Brit Heart J 1978; 40: 1069–1118.

World Health Organisation. Prevention of Coronary Heart Disease. Technical Report Series 678. 1982: WHO Geneva.

European Atherosclerosis Society. Strategies for the prevention of coronary heart disease. Eur Heart J 1987; 8: 77–88.

McEwan SR . Prevention in practice, an MOT for men. Practitioner, 1987; 23:1143–45.

Martin MJ Hulley SB Browner WS Kuller LH Wentworth D. Serum cholesterol, blood pressure and mortality: Implications from a cohort of 361,666 men. Lancet 1986; ii: 933–36.

Lipid Research Clinics Program. The lipid research clinics coronary prevention trial results. JAMA 1984; 251: 351–64.

Frick MH Elo O Haapa K Heinonen OP Heinsalmi P Helo P Huttenen J Helsinki Heart Study: Primary prevention trial with gemfibrozil in middle-aged men with dyslipidaemia. New Engl J Med 1987; 317: 1237–45.

Riemersma RA Wood DA Butler S Elton RA Oliver M Salo M. Linoleic acid content in adipose tissue and coronary heart disease. Brit Med J 1986; 292: 1423–27.

Wood DA Riemersma RA Butler S Linoleic and eicosapentaenoic acids in adipose tissue and platelets and risk of coronary heart disease. Lancet 1987; i: 179–82.

Marmot MG . Interpretation and trends in coronary heart disease mortality. Act Med Scand Suppl 1985; 701: 58–65.

Kromhaut D Bosschieter EB Coulander C de L. The inverse relationship between fish consumption and 20-year mortality from coronary heart disease. New Engl J Med 1985; 312: 1205–9.

Meade TW . Thrombosis and ischaemic heart disease. Brit Heart J 1985; 53: 473–76.

Meade TW Brozovic M Chakrabarti RR Haemostatic function and ischaemic heart disease, principal results of the Northwick Park heart study. Lancet 1986; ii: 533–37.

Stone MC Thorp JM . Plasma Fibrinogen — A major coronary risk factor. J Roy Coll Gen Pract 1985; 35: 565–69.

Miller GJ Walter SJ Stirling Y Thompson SG Esnouf MP Meade TW . Assay of factor VII activity by two techniques: Evidence for increased conversion of VII to alpha VIIa in hyperlipidaemia, with possible implications for ischaemic heart disease. Brit J Haematol 1985; 59:249–58.

Lowe GDO McArdle BM Stromberg P Lorimer AR Forbes CD Prentice CRM . Increased blood viscosity and fibrinolytic inhibitor and type II hyperlipoproteinaemia. Lancet 1982; i: 472–75.

Lowe GDO Machado SG Krot WF Barton BA Forbes CD . White blood cell count and haematocrit as predictors of coronary recurrence after myocardial infarction. Thromb Haemostat 1985; 54: 700–703.

Shepherd J Packard CJ . Editorial: Regression of coronary atherosclerosis: Is it possible? Brit Heart J 1988; 59: 149–150.

Anon Joint Working Party of Royal College of Physicians and British Cardiac Society. J Roy Coll Phys 1976; 10: 213.

Royal College of General Practitioners. Health and prevention in primary care. Report No 18 London; RCGP 1981.

Royal College of General Practitioners. Prevention of arterial disease in general practice. Report No 19 London; RCGP 1981.

Royal College of General Practitioners. Promoting prevention. Report No 22 London; RCGP 1983.

European collaborative trial of multifactorial prevention of coronary heart disease: final report on the six-year results. Lancet 1986; i: 869–72.

WHO expert committee report. Community prevention and control of cardiovascular disease. 1986; Tech series report 732.

Lewis B Mann JI Mancini M. Reducing the risks of coronary heart disease in individuals and in the population. Lancet 1986; i: 956–59.

Hart JT . Semi-continuous screening of a whole community for hypertension. Lancet 1970; ii: 223–226.

Fullard E Fowler GH Gray M. Facilitating prevention in primary care. Brit Med J 1984; 289: 1585–87.

Towards better general practice. Lancet Editorial 1984; ii: 1436–38.

McEwan SR . Better general practice. Lancet 1985; i: 166.